Scarica l'app Stockscreener
65.08
5.66%
3.455
Dopo l'orario di chiusura:
64.17
-0.915
-1.41%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DXCM Giù?
Forum
Previsione
Frazionamento azionario
Dexcom Inc Borsa (DXCM) Ultime notizie
Dexcom stock (US2521311074): Analyst moves follow Elliott deal and new long-term targets - AD HOC NEWS
DexCom Stock Jumps As 2030 Targets Ignite Bullish Trading - StocksToTrade
Dexcom Reveals Flex CGM for Type 2 Diabetes Patients - Medical Product Outsourcing
DexCom (DXCM) Introduces Dexcom Flex for Type 2 Diabetes Patients - GuruFocus
DexCom, Inc. Stock 12‑Month Price Target Cut to $82.28, Implies 34% Upside - TradingView
Wearables in Pharma & Biotech Research and Forecasts Report 2026-2031, Company Profiles and Market Strategies of Abbott, Dexcom, and Masimo - Yahoo Finance
BofA Securities Adjusts Price Target on DexCom to $80 From $100 - marketscreener.com
Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany - The Joplin Globe
DexCom Stock Jumps After Diabetes Management Firm Reaches Agreement With Elliott Investment Management - TIKR.com
Dexcom Inc. stock (US2521311074): diabetes tech player in focus after recent share move - AD HOC NEWS
DexCom, Inc. (DXCM) Analyst/Investor DaySlideshow (NASDAQ:DXCM) 2026-05-17 - Seeking Alpha
DexCom Inc. stock outperforms competitors on strong trading day - MSN
DexCom Inc. stock underperforms Friday when compared to competitors - MSN
Elliott strikes Dexcom board settlement after taking stake - MSN
symbol__ Stock Quote Price and Forecast - CNN
Stephens Investment Management Group LLC Boosts Stock Position in DexCom, Inc. $DXCM - MarketBeat
Assessing DexCom (DXCM) Valuation After Investor Day Targets And New US$1b Buyback Plan - Yahoo Finance
Did New Long-Term Targets and US$1 Billion Buyback Just Shift DexCom's (DXCM) Investment Narrative? - Yahoo Finance
Here's why you should hold DexCom stock in your portfolio for now - MSN
DexCom Maps G8 Launch, Coverage Expansion and Double-Digit Growth at Investor Day - sharewise.com
DexCom Stock Jumps As 2030 Growth Targets And Buybacks Ignite Bullish Momentum - timothysykes.com
DexCom (DXCM) Unveils Ambitious Financial Targets and Share Repu - GuruFocus
Elliott to get two board seats at Dexcom ahead of investor day - MSN
DNB Asset Management AS Boosts Position in DexCom, Inc. $DXCM - MarketBeat
Bank Julius Baer & Co. Ltd Zurich Sells 98,913 Shares of DexCom, Inc. $DXCM - MarketBeat
DexCom (DXCM) Posts Upbeat 2026, Climbs 6.6% - Insider Monkey
DexCom Inc (DXCM) Shares Surge 6.6% -- What GF Score of 88 Tells Investors - GuruFocus
Michael Brown reports two 1,700-share DXCM sales through Morgan Stanley (DXCM) - Stock Titan
Dexcom to add 2 board directors with activist investor Elliott - MedTech Dive
DexCom (DXCM) Shares Rise 5.5% Amid Market Decline - GuruFocus
DexCom (DXCM) Is Trending on Elliott’s Deal, but Execution Is Still the Real Story - AlphaStreet
Diabetes Tech Player DexCom Lays Out 2030 Growth VisionDexCom (NASDAQ:DXCM) - Benzinga
Dexcom, Inc. (DXCM) 8-K SEC Filing Details: Company Info, Address, and Trading Information (May 14, 2026) - Minichart
Why is DexCom stock surging today? By Investing.com - Investing.com Canada
DexCom Long-Range Plan Establishes Respectable Base Case, RBC Says - Moomoo
Elliott Takes Dexcom Stake in Bet on Glucose Monitors Market - Bloomberg.com
DexCom DXCM Draws Bullish Analyst Wave As Governance Shifts - timothysykes.com
Barclays Cuts DexCom Price Target to $64 From $67, Maintains Underweight Rating - marketscreener.com
Dexcom stock (US2521311074): 2030 targets and $1 billion buyback in focus - AD HOC NEWS
DexCom Expects Organic Revenue Growth of Above 10% Per Year Through 2030 - Moomoo
DexCom Stock Draws Bullish Targets As Governance Shifts - StocksToTrade
Piper Sandler reiterates Dexcom stock rating after investor meeting By Investing.com - Investing.com
Here's Why DexCom (DXCM) is a Strong Value Stock - Yahoo Finance
Truist reiterates Buy on DexCom stock, cites growth potential By Investing.com - Investing.com Canada
Canaccord Genuity Adjusts DexCom Price Target to $82 From $100, Maintains Buy Rating - marketscreener.com
DexCom, Inc. announces an Equity Buyback for $1,000 million worth of its shares. - marketscreener.com
Tranche Update on DexCom, Inc.'s Equity Buyback Plan announced on May 1, 2025. - marketscreener.com
Benchmark reaffirms Dexcom stock rating after growth strategy event - Investing.com
Are Wall Street Analysts Bullish on DexCom’s Stock? - Barchart.com
DXCM: DexCom Sees Strong Premarket Gains Amid Market Declines - GuruFocus
Dexcom Unveils 2030 Targets and $1 Billion Buyback - TipRanks
DexCom, Inc. $DXCM Shares Sold by Swiss Life Asset Management Ltd - MarketBeat
Dexcom stock (US2521311074): shares react to latest growth outlook in glucose monitoring - AD HOC NEWS
DXCM Stock Price, Quote & Chart | DEXCOM INC (NASDAQ:DXCM) - ChartMill
DexCom: Governance Enhancements Announced Ahead Of 2026 Investor Day - Pulse 2.0
Insider Sell: Bridgette Heller Sells Shares of DexCom Inc (DXCM) - GuruFocus
3.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):